TickerFacts.

Lineage Cell Therapeutics, Inc. (LCTX): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.28
Year ended 2025-12-31
$0.342014-12-31: -$0.552015-12-31: -$0.592016-12-31: $0.342017-12-31: -$0.172022-12-31: -$0.152023-12-31: -$0.122024-12-31: -$0.092025-12-31: -$0.28-$0.28
2014-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$0.28n/m2026-03-05, From 2025-01-01
2024-12-31-$0.09n/m2026-03-05, From 2024-01-01
2023-12-31-$0.12n/m2025-03-10, From 2023-01-01
2022-12-31-$0.15n/a2024-03-07, From 2022-01-01
No annual figure between 2017-12-31 and 2022-12-31.
2017-12-31-$0.17n/m2018-03-15, From 2017-01-01
2016-12-31$0.34n/m2018-03-15, From 2016-01-01
2015-12-31-$0.59n/m2018-03-15, From 2015-01-01
2014-12-31-$0.55n/a2017-03-16, From 2014-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31-$0.28n/m
Relay Therapeutics, Inc. (RLAY)2025-12-31-$1.61n/m
Pelthos Therapeutics Inc. (PTHS)2025-12-31-$23.04n/m
Caribou Biosciences, Inc. (CRBU)2025-12-31-$1.59n/m
LENZ Therapeutics, Inc. (LENZ)2025-12-31-$2.85n/m
TScan Therapeutics, Inc. (TCRX)2025-12-31-$1.00n/m
Alpha Cognition Inc. (ACOG)2025-12-31-$1.18n/m
Alector, Inc. (ALEC)2025-12-31-$1.39n/m
Taysha Gene Therapies, Inc. (TSHA)2025-12-31-$0.34n/m

Compare LCTX, RLAY, PTHS, CRBU side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗